Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Foster, GR; Agarwal, K; Cramp, ME; Moreea, S; Barclay, S; Collier, J; Brown, AS; ... Haber, B; + view all Foster, GR; Agarwal, K; Cramp, ME; Moreea, S; Barclay, S; Collier, J; Brown, AS; Ryder, SD; Ustianowski, A; Forton, DM; Fox, R; Gordon, F; Rosenberg, WM; Mutimer, DJ; Du, J; Gilbert, CL; Asante-Appiah, E; Wahl, J; Robertson, MN; Barr, E; Haber, B; - view fewer (2018) Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial. Hepatology 10.1002/hep.29852 . (In press).

https://ift.tt/2Hg3IQB